title: Is hepatitis virus resistance to antiviral drugs a threat?
authors.affiliation: National Reference Center for Viral Hepatitis B, C and D, Department of Virology, Hôpital Henri Mondor, Université Paris-Est, Créteil, France. jean-michel.pawlotsky@hmn.aphp.fr
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Pawlotsky
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D016174:Hepacivirus / Q000187:drug effects; D006515:Hepatitis B virus / Q000187:drug effects; D019694:Hepatitis B, Chronic / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006518:Hepatitis Viruses / Q000187:drug effects*; D006525:Hepatitis, Viral, Human / Q000188:drug therapy*; D006801:Humans; D009705:Nucleosides / Q000819:agonists; D009711:Nucleotides / Q000819:agonists
chemical_list: D000998:Antiviral Agents; D009705:Nucleosides; D009711:Nucleotides